Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

US Patent 11110130 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extracellular vesicles derived from human liver stem cells (HLSCs)2025
Composition of extracellular vesicles (EVS) and medical uses thereof2025
Composition of extracellular vesicles (EVS) and medical uses thereof2025
Isolation of extracellular vesicles (EVs) from biological fluid samples2022
Composition of extracellular vesicles (EVS) and medical uses thereof2022
Composition of extracellular vesicles (EVS) and medical uses thereof2022
Pancreatic islet-like cell structures and a method of preparing thereof2022
Pharmaceutical carriers containing miRNAs for use in the treatment of renal canc2022
Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic d2020
Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic d2020
Conditioned medium of liver progenitor cells2019
Conditioned medium of liver progenitor cells2019